SVB Leerink analyst Daina Graybosch upgrades Innate Pharma (NASDAQ:IPHA) from Market Perform to Outperform.
SVB Leerink Upgrades Innate Pharma to Outperform
SVB Leerink analyst Daina Graybosch upgrades Innate Pharma (NASDAQ:IPHA) from Market Perform to Outperform.